SCHEMBL861789

SCHEMBL861789

O=C(O)Nc1nc2ncccc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 2/20 0.52
PRMT5 O14744 1/20 0.50
NUDT1 P36639 1/20 0.49
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.46
DAGLA Q9Y4D2 1/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP1A2 P05177 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44
MAOB P27338 1/20 0.44
ADORA2A P29274 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PDE5A O76074 1/20 0.44
METAP2 P50579 1/20 0.44
METAP1 P53582 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29066590 0.86 LMNA (0.60) HPSEPRMT5NUDT1KMT2ALMNA
SCHEMBL1367313 0.85 PRMT5 (0.65) PRMT5KMT2AKDM4EMAPTNPC1
SCHEMBL27593194 0.82 ALDH1A1 (0.49) HPSEPRMT5NUDT1KMT2ALMNA
SCHEMBL12807020 0.82 HPSE (0.48) HPSEPRMT5NUDT1KMT2ALMNA
SCHEMBL4316866 0.82 ALDH1A1 (0.67) PRMT5KMT2ADAGLAKDM4ENPC1
SCHEMBL29623058 0.76 DAGLA (0.56) HPSEPRMT5NUDT1KMT2ALMNA
SCHEMBL9239194 0.76 NUDT1 (0.59) HPSENUDT1KMT2AKDM4ECYP1A2
SCHEMBL2291563 0.76 DAGLA (0.56) HPSEPRMT5NUDT1KMT2ALMNA
SCHEMBL31404329 0.76 NUDT1 (0.59) HPSENUDT1KMT2AKDM4ECYP1A2
SCHEMBL204726 0.75 NPC1 (0.73) KMT2ALMNAKDM4ENPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 EP disclosed
WO-2012068096-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-24 WO disclosed
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed